Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 98, Issue 2, Pages 121-123Publisher
WILEY
DOI: 10.1002/cpt.105
Keywords
-
Categories
Ask authors/readers for more resources
Diabetes is a proinflammatory state and inflammation is crucial in the genesis of vascular complications. While there are many anti-inflammatory strategies, most of which have been shown to reduce inflammation in diabetes, there is sparse data on reduction in cardiovascular events (CVEs). To date, the only anti-inflammatory strategies that have been shown to reduce CVE in diabetes include statins, angiotensin receptor blockers, metformin, and pioglitazone. We also discuss the role of novel emerging therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available